Compare CMND & WORX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMND | WORX |
|---|---|---|
| Founded | 2017 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4M | 1.6M |
| IPO Year | 2021 | 2016 |
| Metric | CMND | WORX |
|---|---|---|
| Price | $0.72 | $1.07 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 930.7K | ★ 1.5M |
| Earning Date | 03-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 21.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,877,629.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.07 | $0.10 |
| 52 Week High | $3.25 | $1.69 |
| Indicator | CMND | WORX |
|---|---|---|
| Relative Strength Index (RSI) | 40.62 | 71.72 |
| Support Level | $0.59 | $0.22 |
| Resistance Level | $1.20 | N/A |
| Average True Range (ATR) | 0.16 | 0.07 |
| MACD | -0.03 | 0.12 |
| Stochastic Oscillator | 15.57 | 60.95 |
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
SCWorx Corp has developed and markets health information technology solutions and associated services that improve healthcare processes and information flow within hospitals. Its software platform enables healthcare providers to simplify, repair, and organize its data, allows the data to be utilized across multiple internal software applications and provides the basis for sophisticated data analytics. The company's solutions are designed to improve the flow of information quickly and accurately between the existing supply chain, electronic medical records, clinical systems, and patient billing functions. It operates in a single segment - health information technology solutions and services, located in a single geographic location - the United States.